Logo image of VYX

NCR VOYIX CORP (VYX) Stock Fundamental Analysis

NYSE:VYX - New York Stock Exchange, Inc. - US62886E1082 - Common Stock - Currency: USD

13.31  -0.18 (-1.33%)

After market: 13.31 0 (0%)

Fundamental Rating

3

Overall VYX gets a fundamental rating of 3 out of 10. We evaluated VYX against 282 industry peers in the Software industry. There are concerns on the financial health of VYX while its profitability can be described as average. VYX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

VYX had positive earnings in the past year.
In the past year VYX has reported a negative cash flow from operations.
In multiple years VYX reported negative net income over the last 5 years.
Of the past 5 years VYX 4 years had a positive operating cash flow.
VYX Yearly Net Income VS EBIT VS OCF VS FCFVYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

With an excellent Return On Assets value of 21.26%, VYX belongs to the best of the industry, outperforming 95.74% of the companies in the same industry.
VYX has a better Return On Equity (81.38%) than 97.52% of its industry peers.
The Return On Invested Capital of VYX (1.21%) is better than 65.96% of its industry peers.
Industry RankSector Rank
ROA 21.26%
ROE 81.38%
ROIC 1.21%
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
VYX Yearly ROA, ROE, ROICVYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

VYX has a better Profit Margin (26.78%) than 92.91% of its industry peers.
In the last couple of years the Profit Margin of VYX has grown nicely.
The Operating Margin of VYX (1.31%) is better than 64.54% of its industry peers.
VYX's Operating Margin has declined in the last couple of years.
The Gross Margin of VYX (20.74%) is worse than 81.91% of its industry peers.
VYX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.31%
PM (TTM) 26.78%
GM 20.74%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
VYX Yearly Profit, Operating, Gross MarginsVYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VYX is destroying value.
Compared to 1 year ago, VYX has less shares outstanding
Compared to 5 years ago, VYX has more shares outstanding
The debt/assets ratio for VYX has been reduced compared to a year ago.
VYX Yearly Shares OutstandingVYX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
VYX Yearly Total Debt VS Total AssetsVYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

VYX has an Altman-Z score of 1.38. This is a bad value and indicates that VYX is not financially healthy and even has some risk of bankruptcy.
VYX has a Altman-Z score of 1.38. This is in the lower half of the industry: VYX underperforms 60.64% of its industry peers.
VYX has a Debt/Equity ratio of 0.97. This is a neutral value indicating VYX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.97, VYX is not doing good in the industry: 72.34% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 1.38
ROIC/WACC0.11
WACC11.04%
VYX Yearly LT Debt VS Equity VS FCFVYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

VYX has a Current Ratio of 1.12. This is a normal value and indicates that VYX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.12, VYX is doing worse than 68.79% of the companies in the same industry.
VYX has a Quick Ratio of 1.12. This is a bad value and indicates that VYX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.96, VYX is doing worse than 75.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.96
VYX Yearly Current Assets VS Current LiabilitesVYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for VYX have decreased strongly by -66.67% in the last year.
Measured over the past years, VYX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -31.03% on average per year.
VYX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -60.40%.
VYX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.39% yearly.
EPS 1Y (TTM)-66.67%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-30.77%
Revenue 1Y (TTM)-60.4%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-28.42%

3.2 Future

VYX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.08% yearly.
Based on estimates for the next years, VYX will show a decrease in Revenue. The Revenue will decrease by -9.14% on average per year.
EPS Next Y78.28%
EPS Next 2Y50.62%
EPS Next 3Y34.08%
EPS Next 5YN/A
Revenue Next Year-9%
Revenue Next 2Y-11.58%
Revenue Next 3Y-9.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VYX Yearly Revenue VS EstimatesVYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
VYX Yearly EPS VS EstimatesVYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

VYX is valuated quite expensively with a Price/Earnings ratio of 33.27.
Based on the Price/Earnings ratio, VYX is valued a bit cheaper than 68.09% of the companies in the same industry.
When comparing the Price/Earnings ratio of VYX to the average of the S&P500 Index (27.30), we can say VYX is valued slightly more expensively.
A Price/Forward Earnings ratio of 13.33 indicates a correct valuation of VYX.
Based on the Price/Forward Earnings ratio, VYX is valued cheaper than 89.01% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of VYX to the average of the S&P500 Index (21.76), we can say VYX is valued slightly cheaper.
Industry RankSector Rank
PE 33.28
Fwd PE 13.33
VYX Price Earnings VS Forward Price EarningsVYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VYX indicates a rather cheap valuation: VYX is cheaper than 95.74% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.43
VYX Per share dataVYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

VYX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VYX's earnings are expected to grow with 34.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.43
PEG (5Y)N/A
EPS Next 2Y50.62%
EPS Next 3Y34.08%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VYX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NCR VOYIX CORP

NYSE:VYX (7/11/2025, 8:04:00 PM)

After market: 13.31 0 (0%)

13.31

-0.18 (-1.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-04 2025-08-04
Inst Owners113.37%
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner Change21.09%
Market Cap1.83B
Analysts85
Price Target14.92 (12.1%)
Short Float %13.88%
Short Ratio10.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.11
Dividend Growth(5Y)N/A
DP1.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)147.53%
Min EPS beat(2)55.59%
Max EPS beat(2)239.46%
EPS beat(4)3
Avg EPS beat(4)87.32%
Min EPS beat(4)-45.76%
Max EPS beat(4)239.46%
EPS beat(8)5
Avg EPS beat(8)35.38%
EPS beat(12)8
Avg EPS beat(12)25.97%
EPS beat(16)10
Avg EPS beat(16)17.12%
Revenue beat(2)1
Avg Revenue beat(2)-0.36%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)0.95%
Revenue beat(4)2
Avg Revenue beat(4)-4.57%
Min Revenue beat(4)-19.37%
Max Revenue beat(4)1.8%
Revenue beat(8)3
Avg Revenue beat(8)10.83%
Revenue beat(12)5
Avg Revenue beat(12)7.13%
Revenue beat(16)6
Avg Revenue beat(16)4.63%
PT rev (1m)3.08%
PT rev (3m)-7.87%
EPS NQ rev (1m)-1.89%
EPS NQ rev (3m)-16.91%
EPS NY rev (1m)0.31%
EPS NY rev (3m)0.68%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.29%
Valuation
Industry RankSector Rank
PE 33.28
Fwd PE 13.33
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B 1.62
P/tB N/A
EV/EBITDA 7.43
EPS(TTM)0.4
EY3.01%
EPS(NY)1
Fwd EY7.5%
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-1.01
OCFYN/A
SpS24.99
BVpS8.23
TBVpS-3.45
PEG (NY)0.43
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 21.26%
ROE 81.38%
ROCE 1.54%
ROIC 1.21%
ROICexc 1.51%
ROICexgc 4.75%
OM 1.31%
PM (TTM) 26.78%
GM 20.74%
FCFM N/A
ROA(3y)4.26%
ROA(5y)2.43%
ROE(3y)-21.78%
ROE(5y)-13.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-36.27%
ROICexcg growth 5Y-25.75%
ROICexc growth 3Y-36.4%
ROICexc growth 5Y-30.51%
OM growth 3Y-43.61%
OM growth 5Y-31.2%
PM growth 3Y208.92%
PM growth 5Y38.43%
GM growth 3Y-8.16%
GM growth 5Y-5.91%
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA 3.42
Cap/Depr 70.65%
Cap/Sales 5.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.96
Altman-Z 1.38
F-Score5
WACC11.04%
ROIC/WACC0.11
Cap/Depr(3y)67.44%
Cap/Depr(5y)68.37%
Cap/Sales(3y)8.12%
Cap/Sales(5y)6.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3Y-44.54%
EPS 5Y-31.03%
EPS Q2Q%-30.77%
EPS Next Y78.28%
EPS Next 2Y50.62%
EPS Next 3Y34.08%
EPS Next 5YN/A
Revenue 1Y (TTM)-60.4%
Revenue growth 3Y-26.63%
Revenue growth 5Y-16.39%
Sales Q2Q%-28.42%
Revenue Next Year-9%
Revenue Next 2Y-11.58%
Revenue Next 3Y-9.14%
Revenue Next 5YN/A
EBIT growth 1Y-93.3%
EBIT growth 3Y-58.63%
EBIT growth 5Y-42.48%
EBIT Next Year376.67%
EBIT Next 3Y74.29%
EBIT Next 5Y46.94%
FCF growth 1Y-203.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-119.74%
OCF growth 3YN/A
OCF growth 5YN/A